Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tryptophanyl-tRNA synthetase, mitochondrial (WARS2), is an enzyme encoded by the WARS2 gene that catalyzes the attachment of tryptophan to its cognate mitochondrial tRNA, a critical step in mitochondrial protein synthesis. This enzyme is a nucleus-encoded mitochondrial protein and part of the aminoacyl-tRNA synthetase family, essential for translating mitochondrial genes into proteins necessary for oxidative phosphorylation and overall cellular energy metabolism. Two forms of tryptophanyl-tRNA synthetase exist in humans: a cytoplasmic form (WARS/WARS1) and a mitochondrial form (WARS2). Mutations in WARS2 have been linked to autosomal recessive intellectual disability, severe early-onset leukoencephalopathy, and movement disorders, confirming its crucial importance in neural development and mitochondrial function. Beyond its canonical aminoacylation role, WARS2 (and related synthetases) may influence angiogenesis and other cellular processes
Not applicable (no approved drugs act directly on WARS2); Mechanisms would involve inhibition or modulation of enzymatic activity if targeted
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tryptophanyl-tRNA synthetase, mitochondrial (WARS2).